iron deficiency anemia - Nursing Case Study

Pathophysiology

• Primary mechanism: Iron deficiency anemia primarily arises from inadequate iron availability, leading to decreased hemoglobin synthesis. Without sufficient iron, erythrocyte production in the bone marrow is impaired, resulting in microcytic, hypochromic red blood cells that are less efficient in oxygen transport.

• Secondary mechanism: The body attempts to compensate for reduced oxygen delivery by increasing cardiac output and redistributing blood flow to vital organs. However, this compensatory response can exacerbate cardiovascular strain, particularly in patients with preexisting heart conditions.

• Key complication: Severe iron deficiency anemia can lead to profound fatigue, diminished physical performance, and compromised immune function. In extreme cases, it may precipitate heart failure due to chronic overexertion of the cardiovascular system, underscoring the critical need for timely diagnosis and management.

Patient Profile

Demographics:

68-year-old female, retired school teacher

History:

• Key past medical history: Chronic kidney disease stage 4, type 2 diabetes mellitus, hypertension, history of gastrointestinal bleeding

• Current medications: Lisinopril, Metformin, Erythropoietin, Ferrous sulfate, Amlodipine

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Severe fatigue and shortness of breath

• Key symptoms: Dizziness, palpitations, pale skin, brittle nails, restless legs, and chest pain on exertion

• Vital signs: Blood pressure 88/54 mmHg, heart rate 122 bpm, respiratory rate 24 breaths per minute, temperature 97.6°F, SpO2 89% on room air

Section 1

New Diagnostic Results:

Upon further investigation, the hematology panel revealed a hemoglobin level of 6.3 g/dL, hematocrit of 19%, and mean corpuscular volume (MCV) of 68 fL, confirming severe microcytic, hypochromic anemia. Serum ferritin was markedly low at 5 ng/mL, and total iron binding capacity (TIBC) was elevated at 520 mcg/dL, reinforcing the diagnosis of iron deficiency anemia. Additionally, serum creatinine was 3.8 mg/dL, indicating worsening renal function, while blood urea nitrogen (BUN) was elevated at 48 mg/dL. The patient's electrolyte panel showed mild hyperkalemia with a potassium level of 5.6 mmol/L, raising concern for potential cardiac complications.

Further echocardiographic examination revealed left ventricular hypertrophy and a reduced ejection fraction of 40%, indicating the early stages of heart failure, likely exacerbated by chronic anemia and underlying hypertension. The combination of renal impairment and cardiac dysfunction necessitates a delicate balance in managing fluid status and electrolyte levels to prevent further deterioration. These findings highlight the need for a multidisciplinary approach, involving nephrology, cardiology, and hematology, to optimize the patient's care plan.

This complex clinical picture underscores the importance of prioritizing interventions to address both the anemia and its systemic effects. Immediate considerations include initiating intravenous iron supplementation due to poor oral absorption and possible erythropoietin resistance secondary to renal failure. Continuous cardiac monitoring is essential to detect arrhythmias, as the patient's tachycardia and hypotension pose a significant risk for decompensation. As the team formulates a comprehensive management strategy, they must remain vigilant for potential complications such as fluid overload, worsening heart failure, and electrolyte imbalances, which require precise clinical judgment to navigate successfully.

Section 2

Response to Interventions:

After initiating intravenous iron supplementation, the patient initially demonstrated mild improvements in energy levels and a slight increase in hemoglobin to 7.1 g/dL over the first 48 hours. However, continuous cardiac monitoring revealed frequent premature ventricular contractions (PVCs), likely exacerbated by the patient's existing hyperkalemia and underlying cardiac dysfunction. Despite careful management, the patient's blood pressure remained labile, alternating between hypotensive episodes with readings as low as 85/55 mmHg and periods of hypertension. These fluctuations complicated efforts to stabilize the patient's cardiovascular status and required frequent adjustments in medication.

The nephrology team adjusted the patient's diuretic regimen to address fluid overload, as signs of pulmonary congestion became evident, with bilateral crackles auscultated in the lung bases. However, this intervention was met with a new complication: the patient's renal function further deteriorated, evidenced by an increase in serum creatinine to 4.2 mg/dL, and a BUN level escalating to 55 mg/dL. Additionally, the potassium level remained elevated at 5.9 mmol/L, heightening the risk of serious arrhythmias. The balancing act between managing fluid status and preventing renal further compromise became increasingly precarious.

In light of these developments, the multidisciplinary team emphasized the need for a more aggressive approach to managing the patient's electrolytes and renal function, including potential initiation of renal replacement therapy. The cardiology team considered the need for more advanced cardiac support to prevent progression to overt heart failure. This dynamic and evolving clinical scenario demanded heightened vigilance and adaptability from the healthcare team, underscoring the complexity of managing severe iron deficiency anemia with multi-organ involvement. The focus remained on carefully titrating interventions to stabilize the patient while avoiding additional complications.

Section 3

Change in Patient Status:

Within the next 24 hours, the patient's condition took a concerning turn. Despite ongoing management, the patient developed acute shortness of breath and increased respiratory distress. The respiratory rate climbed to 30 breaths per minute, with oxygen saturation dropping to 88% on room air, necessitating immediate supplemental oxygen via a non-rebreather mask. Upon reassessment, the patient's lung sounds revealed worsening bilateral crackles, now extending to the mid-lung fields, indicating advancing pulmonary edema. This respiratory compromise was accompanied by increasing fatigue and confusion, raising concerns about cerebral hypoxia and the potential onset of acute respiratory failure.

Concurrently, the telemetry monitor detected a progression in the cardiac arrhythmias; the frequency of PVCs increased, and episodes of non-sustained ventricular tachycardia emerged. These arrhythmic events were compounded by a further drop in the hemoglobin level to 6.9 g/dL, despite the recent iron supplementation. The patient's blood pressure continued to be erratic, with systolic readings plummeting to 80 mmHg during episodes of ventricular tachycardia, significantly compromising perfusion. The multidisciplinary team convened urgently, recognizing that the patient's complex presentation now included a precarious balance of severe anemia, worsening cardiac instability, and acute respiratory compromise.

In response to these alarming developments, the healthcare team intensified their interventions. The cardiology team recommended the initiation of an antiarrhythmic agent to stabilize the cardiac rhythm, while the nephrology team expedited the preparation for renal replacement therapy to address the worsening renal function and persistent hyperkalemia. The critical care team considered the need for mechanical ventilation to support the patient's deteriorating respiratory status. This cascade of events underscored the fragility of the patient's condition, highlighting the urgent need for comprehensive, coordinated care to navigate the intricate interplay of multi-organ dysfunction.

Section 4

As the healthcare team responded to the patient's critical condition, the next 12 hours brought a series of new challenges that tested the limits of clinical expertise and judgment. The initial response to the antiarrhythmic agent was promising, with the frequency of PVCs reducing. However, the episodes of non-sustained ventricular tachycardia persisted, suggesting underlying myocardial irritability. Meanwhile, efforts to stabilize his hemoglobin levels with continued intravenous iron supplementation and packed red blood cell transfusions showed only marginal improvements, with the latest hemoglobin value reaching 7.2 g/dL. Despite these measures, the patient's systolic blood pressure remained labile, intermittently dropping to critical lows of 75 mmHg, further jeopardizing organ perfusion.

New diagnostic results added layers of complexity to the clinical picture. An echocardiogram revealed a markedly reduced ejection fraction of 30%, indicating significant left ventricular dysfunction possibly exacerbated by the anemia-induced high-output cardiac failure. In parallel, the renal function showed no signs of improvement; serum creatinine levels escalated to 3.8 mg/dL, and potassium stabilized at a dangerous 6.2 mmol/L, reinforcing the nephrology team's decision to initiate renal replacement therapy in the form of continuous venovenous hemofiltration (CVVH). Arterial blood gas analysis confirmed the suspicion of respiratory compromise, showing a pH of 7.31, a pCO2 of 55 mmHg, and a pO2 of 60 mmHg on 100% oxygen, indicative of type II respiratory failure.

The patient's response to the initial interventions was mixed, presenting a critical juncture for the healthcare team to reassess and recalibrate their treatment strategy. The initiation of CVVH began to stabilize electrolyte imbalances, yet the patient's mental status fluctuated, with periods of confusion interspersed with brief lucidity, raising concerns about ongoing cerebral hypoxia. The critical care team decided to proceed with intubation and mechanical ventilation to ensure adequate oxygenation and ventilation, aiming to alleviate the respiratory muscles' workload and stabilize gas exchange. As these interventions unfolded, the team remained vigilant for potential complications, including infection risk associated with invasive procedures and the possibility of further cardiac decompensation. The intricate balance of managing multi-organ dysfunction continued to challenge the team's expertise, demanding continuous monitoring and dynamic adaptation of the care plan.

Section 5

As the intubation procedure was successfully completed, the team noted immediate improvements in the patient's oxygen saturation, now consistently above 94%. However, the stability was short-lived as new complications arose. Within hours, the patient's temperature spiked to 39.2°C, prompting an urgent assessment for potential sources of infection. Blood cultures were drawn, and broad-spectrum antibiotics were initiated empirically. Despite these measures, the patient's white blood cell count climbed to 18,000/mm³, and procalcitonin levels were markedly elevated, suggesting a systemic inflammatory response and possible sepsis, likely secondary to the invasive interventions performed earlier.

Concurrently, the patient's cardiovascular status deteriorated further. Despite vasopressor support with norepinephrine, his blood pressure remained critically low, with mean arterial pressures consistently below 60 mmHg, raising alarms about inadequate perfusion to vital organs. A repeat echocardiogram confirmed the worsening cardiac function, with an ejection fraction now reduced to 25%. Cardiac biomarkers revealed a significant rise in troponin I levels to 2.5 ng/mL, indicating ongoing myocardial injury, likely exacerbated by the persistent hypotension and possibly a septic cardiac dysfunction exacerbating the previous high-output failure.

Amidst these developments, the healthcare team faced the arduous task of juggling the management of concurrent sepsis and cardiac failure. The nephrology team suggested transitioning from continuous venovenous hemofiltration to intermittent hemodialysis to address the severe fluid overload, which was now contributing to pulmonary edema, as evidenced by new bilateral infiltrates on a repeat chest X-ray. The decision was made with caution, recognizing the risk of hemodynamic instability. The team also deliberated the need for a possible intra-aortic balloon pump insertion to support the failing heart, weighing the risks and benefits carefully in this fragile patient. These discussions underscored the critical juncture at which the team found themselves, navigating complex, overlapping pathologies with a clear mandate to stabilize the patient while preventing further decompensation.